|
Symposium
[Free Online] Innovative Life Science Technologies in the Drug Development Toolbox: From Cancer Organoids and Biomarker Profiling to Label-Free Multiplex QES Assays
Speakers:
Aihua Fu, NVIGEN; Emily Miyashita-Lin, Cellentia; Chaitanya Gupta, Probius; Joseph de Rutte, Partillion Bioscience; Andrew Chang, DeepSeq.AI; Xiaoxi Wei, X-Therma Inc.; Samuel Tia, Correlia Biosystems
Organizers:
Shian Jiun Shih (Cellentia, Inc.), Aihua Fu (NVIGEN), Alex Yang (Vir Biotechnology)
Date:
2024-04-12
Time:
8:30-13:30 Pacific Time
Registration fee:
0
Location:
Online via Zoom
Major Sponsor:
Vendor show vendors registered to date:
Registration: http://www.PBSS.org
Registration deadline:2024-04-11
(it will close sooner if the seating cap is reached)
About the Topic
The abstract of this symposium:
The era of one-size-fits-all pharmaceuticals is fading. Today, the drug development landscape brims with groundbreaking modalities - from gene and cell therapies to mRNA and antibody-drug conjugates (ADCs) armed with radiotherapy. This transformative journey demands equally disruptive tools to streamline and accelerate research. Join us at this symposium as we explore the frontier of technology propelling the discovery of next-generation therapeutics. This symposium will showcase a diverse arsenal of tools designed to empower every stage of drug development. Topics include single-cell analysis, AI-based protein design, cancer organoids for drug screening, multiplex assays sans detecting agents, and sensitive NGS/multiomic biomarker profiling assays revealing previously hidden disease complexity. These advancements reflect the continuous pursuit of innovation, accelerating the quest for more effective, targeted, and ultimately, transformative therapeutic solutions.
|
Time (PT)
|
Topic
|
Speaker
|
|
8:30-8:40 am
|
PBSS Welcome and Introduction
|
Shichang Miao, PhD, PBSS
|
|
8:40-9:15 am
|
Novel Non-Invasive Organoid Platform from Cancer Patient Circulating Tumor Cells for Drug Screening and Monitoring
|
Emily Miyashita-Lin, Director, Cellentia
|
|
9:15-9:50 am
|
Expand Your Functional Toolkit: Nanovial Assays for Drug Discovery and Development
|
Joseph De Rutte, CEO and Co-founder, Partillion Bioscience
|
|
9:50-10:25 am
|
Evaluation of the PIXI™ Automated Platform for Rapid, Micro-volume PK Measurements
|
Samuel Tia, CSO and Co-founder, Correlia Biosystems
|
|
10:25-10:35 am
|
Break
|
-
|
|
10:35-11:10 am
|
Crack the Biomarker Code: Accelerate Drug Development with NVIGEN's Precision Medicine Biomarker Profiling Assays
|
Aihua Fu, CEO and Co-founder, NVIGEN
|
|
11:10-11:45 am
|
Simplifying Bio Analytical Assay Development: The Quantum Electrochemical Spectroscopy (QES) Approach
|
Chaitanya Gupta, CTO and Co-founder, Probius
|
|
11:45-12:20 pm
|
A Tale of a Golden Shovel in the Gold Rush: Next-Generation DMSO-Free & Serum-Free Biopreservation for Cell & Gene Therapies and Engineered Tissues Manufacturing And Processing
|
Xiaoxi (Sofie) Wei,CEO and Co-founder, X-Therma
|
|
12:20-12:55 pm
|
Unlocking the Potential of Explainable AI in Designing Functional Protein Libraries
|
Andrew Chang,CEO and Co-founder, DeepSeq AI
|
|
12:55-1:25 pm
|
Q&A and Panel discussion
|
All Speakers
|
2024-08-14, [Free Online] Advances in Cancer Therapeutics (Organized by PBSS and BioScience Forum)
|
2024-08-22, [Free Online] Diabetes and Obesity Treatments: Current and Emerging Landscapes of GLP-1, GIP, and Beyond
|
2024-09-10, [In-Person] Translational PK/PD and Human Dose Projection for Antibodies/ADCs and Novel Therapeutic Modalities
|
2024-09-20, [In-Person] Nonclinical Safety Assessments of Biologics and Other Novel Modalities for IND/NDA/BLA Filings
|
2024-09-25, [Free Online] Development of Protein Degraders: Computational Modeling, Medicinal Chemistry and Early Development
|
2024-10-10, [In-Person] Regulatory Global Submission: Strategies and Best Practices for FDA, EMA and PMDA
|
2024-10-25, [Free Online Workshop] Unleashing the Power of Real-World Evidence / Data (RWE/RWD) to Facilitate Drug Discovery, Development, and Beyond
|
2024-11-01, [In-Person] Clinical Pharmacology Studies on Hepatic and Renal Impairments for NDA Filing: Strategies, Design, Conduct, Analysis and Regulatory Aspects
|
2024-11-13, [Free Online Workshop] Career Transition for Research Scientists: Business Development & BioPartnering
|
2024-11-15, [In-Person] Bioanalysis for Biologics and Cell/Gene Therapy Products: Refining Established Approaches for New Complex Therapeutics
|
2025-01-22, [In-Person] Small-Molecule Formulation for Discovery & Early Development (jointly by PBSS / AAPS-BADG / Syner-G)
|
|
Ads (in random order)
Submit a Text Ad
($250 for 2 months)
Simulations Plus
GastroPlus X: Science, models & refined algorithms—now with intuitive interface, faster processing & streamlined workflows for faster PBPK modeling.
|
Alturas Analytics, Inc.
Expert Regulated & Non-Regulated LC-MS, GC-MS bioanalytical & PK/TK analysis of small & large molecules in any matrix. Discovery through phase IV.
|
Submit a Text Ad
|